34908 Federal Register / Vol. 63, No. 123 / Friday, June 26, 1998 / Notices

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute on Deafness and

Other Communication Disorders;

Notice of Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Institute on

Deafness and Other Communications

Disorders Special Emphasis Panel.

Date: July 31, 1998.

Time: 12:00 pm to 3:00 pm.

Agenda: To review and evaluate grant

applications.

Place: 6120 Executive Blvd, Suite 400C,

Bethesda, MD 20892, (Telephone Conference

Call).

Contact Person: George M. Barnas, PhD,

Scientific Review Administrator, Scientific

Review Branch, Division of Extramural

Activities/NIDCD, 6120 Executive Blvd.,

Bethesda, MD 20892, 301–496–8683.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.173, Biological Research

Related to Deafness and Communicative

Disorders, National Institutes of Health, HHS)

Dated: June 18, 1998.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 98–17000 Filed 6–25–98; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute on Alcohol Abuse

and Alcoholism; Notice of Closed

Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552(c)(6), Title 5 U.S.C.,

as amended. The grant applications

and/or contract proposals and the

discussions could disclose confidential

trade secrets or commercial property

such as patentable material, and

personal information concerning

individuals associated with the grant

applications and/or contract proposals,

the disclosure of which would

constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Institute on

Alcohol Abuse and Alcoholism Special

Emphasis Panel.

Date: July 14–16, 1998.

Time: 7:00 pm to 5:00 pm.

Agenda: To review and evaluate grant

applications.

Place: Radisson Barcelo Hotel, 2121 P St.,

NW, Washington, DC 20037.

Contact Person: Mark R. Green, PhD.,

Chief, Extramural Division Branch, National

Institute on Alcohol Abuse and Alcoholism,

Suite 409, 6000 Executive Blvd., Bethesda,

MD 20892.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.271, Alcohol Research

Career Development Awards for Scientists

and Clinicians; 93.272, Alcohol National

Research Service Awards for Research

Training; 93.273, Alcohol Research Programs;

93.891, Alcohol Research Center Grants,

National Institutes of Health, HHS)

Dated: June 19, 1998.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 98–17001 Filed 6–26–98; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute on Drug Abuse;

Notice of Closed Meetings

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meetings.

The meetings will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications

and/or contract proposals and the

discussions could disclose confidential

trade secrets or commercial property

such as patentable material, and

personal information concerning

individuals associated with the grant

applications and/or contract proposals,

the disclosure of which would

constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Institute on

Drug Abuse Special Emphasis Panel,

Training and Career Development

Committee.

Date: June 29–July 1, 1998.

Time: June 29, 1998, 9:00 am to

Adjournment.

Agenda: To review and evaluate grant

applications.

Place: Sheraton Crystal City Hotel, 1800

Jefferson Davis Highway, Arlington, VA

22202.

Contact Person: Mark Swieter, PhD, Health

Scientist Administrator, Office of Extramural

Program Review, National Institute on Drug

Abuse, National Institutes of Health, DHHS,

5600 Fishers Land, Room 10–42, Rockville,

MD 20857, (301) 443–2620.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

Name of Committee: National Institute on

Drug Abuse Special Emphasis Panel,

Training and Career Development

Committee.

Date: June 29, 1998.

Time: 5:30 pm to Adjournment.

Agenda: To review and evaluate grant

applications.

Place: Sheraton Crystal City Hotel, 1800

Jefferson Davis Highway, Arlington, VA

22202.

Contact Person: Mark Swieter, PhD, Health

Scientist Administrator, Office of Extramural

Program Review, National Institute on Drug

Abuse, National Institutes of Health, DHHS,

5600 Fishers Land, Room 10–42, Rockville,

MD 20857, (301) 443–2620.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

Name of Committee: National Institute on

Drug Abuse Special Emphasis Panel, Rodent

and Monkey Testing for NIDA Medication

Discovery Program.

Date: June 30, 1998.

Time: 10:30 am to Adjournment.

Agenda: To review and evaluate contract

proposals.

Place: National Institute on Drug Abuse,

5600 Fishers Land, Room 10–49, Rockville,

MD 20857, (301) (Telephone Conference

Call).

Contact Person: Eric Zatman, Contract

Review Specialist, Office of Extramural

Program Review, National Institute on Drug

Abuse, National Institutes of Health, DHHS,

5600 Fishers Lane, 10–42, Rockville, MD

20857, (301) 443–1644.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

Name of Committee: National Institute on

Drug Abuse Initial Review Group, Treatment

Research Subcommittee.

Date: July 8–9, 1998.

Time: July 8, 1998, 8:30 am to 12:00 pm.

Agenda: To review and evaluate grant

applications.

Place: Double Tree Hotel, 1750 Rockville

Pike, Rockville, MD 20852.

Contact Person: Kesinee Nimit, MD, Health

Scientist Administrator, Office of Extramural

Program Review, National Institute on Drug

Abuse, National Institutes of Health, DHHS,